78208-68-1 Usage
Uses
Used in Pharmaceutical Industry:
1,3-Dimethyl-4-nitro-1H-pyrazole-5-carboxylic acid ethyl ester is used as an intermediate in the synthesis of certain drugs for its ability to react with other compounds to form more complex molecules, contributing to the development of new pharmaceutical substances.
Used in Agricultural Industry:
1,3-Dimethyl-4-nitro-1H-pyrazole-5-carboxylic acid ethyl ester is used as an intermediate in the synthesis of agrochemicals, enabling the creation of new substances with potential applications in agriculture for pest control and crop protection.
Used in Research and Development:
1,3-Dimethyl-4-nitro-1H-pyrazole-5-carboxylic acid ethyl ester is used as a building block in the development of new substances and materials, facilitating innovative research in the fields of chemistry and material science.
Used in Bioactive Molecule Exploration:
1,3-Dimethyl-4-nitro-1H-pyrazole-5-carboxylic acid ethyl ester is used in the exploration of bioactive molecules for its potential pharmacological properties, offering opportunities for the discovery of new therapeutic agents and applications in medicine.
Check Digit Verification of cas no
The CAS Registry Mumber 78208-68-1 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,8,2,0 and 8 respectively; the second part has 2 digits, 6 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 78208-68:
(7*7)+(6*8)+(5*2)+(4*0)+(3*8)+(2*6)+(1*8)=151
151 % 10 = 1
So 78208-68-1 is a valid CAS Registry Number.
78208-68-1Relevant academic research and scientific papers
Pyrazolobenzodiazepinones, their intermediates, their compositions and their use
-
, (2008/06/13)
1-(Lower)alkyl-4-(substituted)aminoalkylcarbonyl-1,4,9,10-tetrahydropyrazolo[4,3-b][1,5]benzodiazepin-10-ones are useful, e.g., to protect warm blooded animals against the formation of gastric ulcers. They are active ingredients in otherwise conventional medicament compositions administered enterally or parenterally in standard dosage forms. Their synthesis, their novel intermediates and their acid-addition salts are described.